Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at Transcatheter Cardiovascular Therapeutics, taking place at the Colorado Convention Center in Denver, Colorado, 29 October – 2 November. Clinical Adviser, Professor Bruno Scheller MD, will present CathHELIX: A Novel Transcatheter Mitral Valve Repair System as part […]
Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present data at the 2017 PCR Innovators Day, taking place at ExCel London on 24 September. Clinical Advisor, Professor Bruno Scheller MD, will give a presentation entitled Transcatheter CathHELIX mitral valve repair, at 16.20 GMT. The PCR […]
Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that Medtentia Annuloplasty System initial study data will be presented as an e-poster at the Heart Valve Society Scientific Meeting 2017, taking place between 2-4 March at the Grimaldi Forum, Monaco. E-poster P137 Medtentia Annuloplasty System: Results of an Early […]
The statistical analysis of Medtentia’s proof-of-concept study evaluating the Medtentia Annuloplasty Ring (MAR) has recently been completed. As previously expected based on preliminary data analyses, the main safety- and performance- related objectives of the study were successfully achieved. The newly analyzed results indicate that the MAR ring is well tolerated and induces improvement of heart […]
Medtentia International Ltd is happy to announce the appointment of Hannu Syrjälä as the new Chairman of its Board of Directors. Mr. Syrjälä succeeds Tord Lendau as Chairman starting from the 14th of September, 2016. Mr. Syrjälä has over twenty years of experience in different senior executive roles, including Head of Life Support Solutions Business […]
The long-term data collection for the proof-of-concept study evaluating the Medtentia Annuloplasty Ring (MAR) has recently been completed. The prospective single-arm clinical study assessed MAR safety and performance in 11 adults who underwent mitral valve repair surgery. The collected data is currently being analyzed, and preliminary data analyses have yielded promising results. “The preliminary results […]
Medtentia International Ltd Oy has successfully completed a €8M financing round in March 2015. The round includes a total of €6M in equity from existing and new investors, while the remaining €2M consists of shareholder loans converted into capital. The raised funds will be used mainly to support the development and testing of Medtentia’s catheter-based […]
Medtentia International Ltd Oy today announced that the surgeons at Helsinki University Hospital led by Prof Werkkala have successfully continued to recruit patients for the official second phase of the clinical approval study evaluating the safety and efficacy of the “Medtentia Helix Ring in Adults Undergoing Mitral Valve Repair Surgery”. After review and recommendation by […]
Helsinki, Finland, Oct 26, 2012 – Medtentia International Ltd Oy today announced that the investigators at Helsinki University Hospital have successfully completed the recruitment of patients for the first phase of the clinical study evaluating the safety and performance of the Medtentia Helix Ring in adults undergoing mitral valve repair surgery. The preliminary results after […]